Kestra Advisory Services’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $541K | Sell |
3,528
-103
| -3% | -$15.8K | ﹤0.01% | 1904 |
|
|
2025
Q1 | $571K | Sell |
3,631
-937
| -21% | -$147K | ﹤0.01% | 1728 |
|
|
2024
Q4 | $717K | Sell |
4,568
-851
| -16% | -$134K | ﹤0.01% | 1616 |
|
|
2024
Q3 | $961K | Sell |
5,419
-192
| -3% | -$34.1K | 0.01% | 1342 |
|
|
2024
Q2 | $945K | Buy |
5,611
+192
| +4% | +$32.3K | 0.01% | 1348 |
|
|
2024
Q1 | $901K | Buy |
5,419
+9
| +0.2% | +$1.5K | 0.01% | 1303 |
|
|
2023
Q4 | $894K | Buy |
5,410
+2,349
| +77% | +$388K | 0.01% | 1184 |
|
|
2023
Q3 | $477K | Buy |
3,061
+424
| +16% | +$66K | ﹤0.01% | 1398 |
|
|
2023
Q2 | $412K | Buy |
2,637
+202
| +8% | +$31.5K | ﹤0.01% | 1425 |
|
|
2023
Q1 | $395K | Sell |
2,435
-15,918
| -87% | -$2.58M | ﹤0.01% | 1404 |
|
|
2022
Q4 | $2.93M | Sell |
18,353
-1,668
| -8% | -$266K | 0.03% | 607 |
|
|
2022
Q3 | $2.82M | Buy |
20,021
+2,165
| +12% | +$305K | 0.03% | 544 |
|
|
2022
Q2 | $2.6M | Sell |
17,856
-6,299
| -26% | -$918K | 0.03% | 575 |
|
|
2022
Q1 | $3.92M | Sell |
24,155
-226
| -0.9% | -$36.6K | 0.04% | 440 |
|
|
2021
Q4 | $4.62M | Sell |
24,381
-474
| -2% | -$89.7K | 0.05% | 400 |
|
|
2021
Q3 | $5.02M | Sell |
24,855
-5,987
| -19% | -$1.21M | 0.05% | 388 |
|
|
2021
Q2 | $6.22M | Sell |
30,842
-11,253
| -27% | -$2.27M | 0.07% | 309 |
|
|
2021
Q1 | $7.39M | Buy |
42,095
+1,440
| +4% | +$253K | 0.09% | 247 |
|
|
2020
Q4 | $6.9M | Buy |
40,655
+5,376
| +15% | +$913K | 0.08% | 269 |
|
|
2020
Q3 | $5.72M | Buy |
+35,279
| New | +$5.72M | 0.11% | 225 |
|